Replies to post #20573 on Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Mr. DCSPKA You Said

"What I am wondering is what will be the catalyst for getting the Remaining Retail to sell at .0001. I don't think there is going to be one. At this point in time, I think that the creeping takeover group has what they need and are simply waiting on Patents".

I Said

Patents Patents Patents.. It is so important to protect a good product.There is one person that we know who has many patents in the past> That gentlemen who along with Doug. I admire the most. Ladies and Gentlemen..William Gartner.. If you search my recent posts.You can see his video about a "lung cancer test". Knowing William..He knows how important it is to keep trade secrets under a wrap.. It is Synchronicity that will play the major role in the "catalyst". Between you and me. We have the insight and years of excellent due diligence to figure out this "California Dream". Arizona. By the time I get to Phoenix... I would like to get more information about the Uni Deal..We can only speculate that they will be our Asian manufacturing and distributing partner.The Breast Cancer study for Provista DX is wrapping up this month..They are already in the process of another breast cancer study.... Here is a link from a blast from the past..I will highlight the main report. Most of the other is just "fluff" in my opinion.

Jan. 10, 2011 1:00 PM ET | About: RXPC

On Friday, "All Eyes were on Radient Pharmaceuticals" (RPC) as the company was set to announce whether officials at the NYSE Amex would approve the company's ambitious debt-for-equity swap. What happened next left the market and those who have been following the stock more than a little confused.

As the markets were set to open, during pre-market trading session shares of the company had begun to rise dramatically on heavy volume. Message boards, news sites and trading rooms were buzzing in anticipation of the good news. It didn't hurt that the CEO of the company had just verified that the company was aboout to start ramping up to meet the demands for the biggest order to date of their flagship, early cancer diagnostics test kits. Efforts by new management over the past two years had laid the groundwork for the full commercialization and distribution push- now underway across the globe.

The company had risen in value dramatically from lows in the thirty cent range to highs near $1.70 during the previous two weeks- following the announcement that debt holders, shareholders and the company's board of directors had all come to agree that the debt which was strangling and weighing down the company should be converted to equity. A bewildering number of naked-short positions were suddenly caught in the trade and many of them had already begun to cover, sending shares higher, faster as they did.

By the time the opening bell rang, over a million shares had traded and the stock looked primed to run higher. Then something no one had anticipated occurred. Trading was halted at the opening bell, as officials at the NYSE Amex announced that news for the company was pending. During a few tense moments, panic and confusion set in. Did something go wrong? Was the company getting de-listed?

It's hard to say what may have happened if trading had not been halted, but on Wall Street when a stock is halted pending news, a vast majority of the time things have a tendency to turn ugly ... fast. Exchange officials sometimes let markets go to "time-out" so that shareholders, traders and others can all "get on the same page" about big news. The news here had been not only anticipated, but was the same news that caused so much stir in pre-market hours. The company had officially received their "good news."

The moment trading resumed, shares dropped then bounced off session lows to find some strong stability and support right along the 200-day moving average as the trading day played out.

Could so many have been so wrong? The re-balancing of the company's capitalization had just given Radient Pharmaceuticals the equivalent of a new lease on life. Debt holders didn't want to keep hurting the company. They saw the signs and wanted, instead, a bigger stake in the company for the ride back up.

Analysts, reporters and message boards alike agreed the company's future looked much brighter than it had ever looked. Price targets had been adjusted to reflect even higher marks after the company showed substantive progress and positive sales efforts.

Perhaps most importantly, without bias or a sudden case of mypoic vision, officials at the Amex who carefully reviewed the debt-for-equity details agreed that once they stamped their approval for the deal and re-capitalization set in, company shares would be able to absorb any dilution and still be priced to meet the exchange's minimum listing requirements. Surely the exchange officials were assured by the company that any additional shares that might be issued as part of the swap would be issued in such a manner that would not be disruptive to those listing requirements. That so many tens of millions of naked shorts had to purchase shares has also played into the equation here. (See chart which outlines those requirements here.)

While Radient officials had been telling the market that they had expected to eliminate $33 million in debt and turn liabilities into $22 million in equity. Amex officials let the company eliminate even more debt - thus giving shareholders even better than anticipated news.

http://seekingalpha.com/article/245741-radient-shares-set-to-rebound-following-fall-on-trading-halt-friday

http://wn.com/pharma_notes

[guardiangel]

DCSPKA You Said

"The trading volume has plummeted to only 7-8 million shares a day. Naturally they will continue to buy what Retail casts off, but I don't think there is going to be a big push to get what's left. After all, Retail accounts for less than 15% of the float at this time."

"Wolf Says"

It depends...How much control do the lenders want between them all...Do we have another round of stock transfers? Who knows..I know the lenders are set on the 680 million bid. Not retailers. We have seen this trade pattern going on for a long time..Is it a bluff or a just a chess move to protect its King. "Your Move"... Yes